Equities
  • Price (EUR)6.50
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-18.75%
  • Beta--
Data delayed at least 15 minutes, as of Apr 15 2024 14:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Clarivate Plc is an information services provider. The Company provides information, analytics, professional services and workflow solutions that enable users across government and academic institutions, life science and healthcare companies, corporations and law firms to power the entire lifecycle, from cultivating curiosity to protecting critical intellectual property assets. Its segments include Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H). The A&G segment provides curated, structured content, discovery solutions and related software applications that are embedded into the workflows of its customers, which include libraries, universities and research institutions. Its IP segment consists of patents, trademarks, and IP management products and solutions. The LS&H segment contains its products and solutions, which serve the content and analytical needs of pharmaceutical and biotechnology companies across the drug development lifecycle.

  • Revenue in USD (TTM)2.63bn
  • Net income in USD-1.06bn
  • Incorporated2019
  • Employees12.00k
  • Location
    Clarivate PLC70 St. Mary AxeLONDON EC3A 8BEUnited KingdomGBR
  • Phone+44 207 433 4000
  • Websitehttps://clarivate.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
16A:FRA since
announced
Transaction
value
MotionHall-Asset PortfolioAnnounced21 Mar 202421 Mar 2024Announced-2.26%--
Data delayed at least 15 minutes, as of Apr 15 2024 14:29 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.